Inborn errors of purine and pyrimidine metabolism: A guide to diagnosis

被引:10
作者
Jurecka, Agnieszka [1 ,3 ]
Tylki-Szymanska, Anna [2 ]
机构
[1] CoA Therapeut, Palo Alto, CA USA
[2] Childrens Mem Hlth Inst, Warsaw, Poland
[3] 1800 Owens St,Suite C-1200, San Francisco, CA 94158 USA
关键词
Encephalopathy; Hypotonia; Myopathy; Purines; Pyrimidines; Seizures; ADENYLOSUCCINATE LYASE DEFICIENCY; MITOCHONDRIAL-DNA DEPLETION; BETA-UREIDOPROPIONASE DEFICIENCY; DOMINANT RETINITIS-PIGMENTOSA; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDINE KINASE; HPRT DEFICIENCY; DISORDERS; DEGRADATION; MUTATIONS;
D O I
10.1016/j.ymgme.2022.02.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inborn errors of purine and pyrimidine (P/P) metabolism are under-reported and rarely mentioned in the general literature or in clinical practice, as well as in reviews dedicated to other inborn errors of metabolism (IEMs). However, their diagnosis is important because genetic counseling can be provided and, in some cases, specific treatment exists that may slow or even reverse clinical signs. The purpose of this review is to provide a practical guideline on the suspicion and investigation of inborn errors of P/P metabolism. Failure of a physician to recognize the presence of these disorders may be devastating for affected infants and children because of its permanent effects in the patient, and for their parents because of implications for future offspring. Diagnosis is crucial because genetic counseling can be provided and, in some cases, specific treatment can be offered that may slow or even reverse clinical symptoms. This review highlights the risk factors in the history, the important examination findings, and the appropriate biochemical investigation of the child. Herein we describe the approach to the diagnosis of P/P disorders and emphasize clinical situations in which physicians should consider these diseases as diagnostic possibilities.
引用
收藏
页码:164 / 176
页数:13
相关论文
共 75 条
  • [1] Metabolic Seizures
    Almannai, Mohammed
    Al Mahmoud, Rabah A.
    Mekki, Mohammed
    El-Hattab, Ayman W.
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [2] [Anonymous], 2005, CLIN GUIDE INHERITED
  • [3] Asadov Chingiz, 2017, Cardiovascular & Hematological Agents in Medicinal Chemistry, V15, P23, DOI 10.2174/1871525715666170529091921
  • [4] β-ureidopropionase deficiency presenting with febrile status epilepticus
    Assmann, BE
    Kuilenburg, ABP
    Distelmaier, F
    Abeling, NGGM
    Rosenbaum, T
    Schaper, J
    Duran, M
    Mayatepek, E
    [J]. EPILEPSIA, 2006, 47 (01) : 215 - 217
  • [5] Inborn errors of pyrimidine metabolism: clinical update and therapy
    Balasubramaniam, Shanti
    Duley, John A.
    Christodoulou, John
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (05) : 687 - 698
  • [6] Bierau J., 2014, PHYS GUIDE DIAGNOSIS
  • [7] Blau N., 2003, Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases, V2nd ed.
  • [8] Inborn errors of metabolism in infancy: A guide to diagnosis
    Burton, BK
    [J]. PEDIATRICS, 1998, 102 (06) : E69
  • [9] GOUT, URIC-ACID AND PURINE METABOLISM IN PEDIATRIC NEPHROLOGY
    CAMERON, JS
    MORO, F
    SIMMONDS, HA
    [J]. PEDIATRIC NEPHROLOGY, 1993, 7 (01) : 105 - 118
  • [10] Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing
    Caudle, K. E.
    Thorn, C. F.
    Klein, T. E.
    Swen, J. J.
    McLeod, H. L.
    Diasio, R. B.
    Schwab, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (06) : 640 - 645